Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
Methods in Molecular Biology (Clifton, N.J.)
|
September 30, 2025
A 3D Co-Culture Model of Endometrial Carcinoma Cells with Peripheral Blood Immune Cells (PBMCs) to Study the Activity of Immune Checkpoint Inhibitors
Justyna Kocik-Krol, Marcin Krzykawski
Methods in Molecular Biology (Clifton, N.J.)
|
September 30, 2025
A PD-1/PD-L1-Sensitive Co-culture-Based Primary T-Cell Activation Assay
Justyna Kocik-Krol, Malgorzata Stec, Maciej Siedlar, et al.
International Journal of Molecular Sciences
|
November 13, 2021
PD-L1 Inhibitors: Different Classes, Activities, and Mechanisms of Action
Ewa Surmiak, Katarzyna Magiera-Mularz, Bogdan Musielak, et al.
ACS Medicinal Chemistry Letters
|
July 16, 2025
Characterization of Clinically Evaluated Small-Molecule Inhibitors of PD-L1 for Immunotherapy
Alicja Slota, Katarzyna Golebiowska-Mendroch, Justyna Kocik-Krol, et al.
Molecular Cancer
|
September 7, 2023
Structural and biological characterization of pAC65, a macrocyclic peptide that blocks PD-L1 with equivalent potency to the FDA-approved antibodies
Ismael Rodriguez, Justyna Kocik-Krol, Lukasz Skalniak, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
December 5, 2025
Balancing cell cycle arrest and immune activation: A synergistic window for idasanutlin and anti-PD-1 therapy in a syngeneic mouse model
Aneta Nieznanska, Malgorzata Statkiewicz, Zuzanna Sandowska-Markiewicz, et al.
Molecules (Basel, Switzerland)
|
June 10, 2022
Biphenyl Ether Analogs Containing Pomalidomide as Small-Molecule Inhibitors of the Programmed Cell Death-1/Programmed Cell Death-Ligand 1 Interaction
Shabnam Shaabani, Louis Gadina, Ewa Surmiak, et al.
Journal of Medicinal Chemistry
|
July 27, 2021
Terphenyl-Based Small-Molecule Inhibitors of Programmed Cell Death-1/Programmed Death-Ligand 1 Protein-Protein Interaction
Damian Muszak, Ewa Surmiak, Jacek Plewka, et al.
ACS Medicinal Chemistry Letters
|
January 17, 2024
Solubilizer Tag Effect on PD-L1/Inhibitor Binding Properties for <i>m</i>-Terphenyl Derivatives
Ewa Surmiak, Julia Ząber, Jacek Plewka, et al.
Anticancer Research
|
September 30, 2024
Therapeutic Responses to Two New SN-38 Derivatives in Colorectal Cancer Patient-Derived Xenografts and Respective 3D <i>In Vitro</i> Cultures
Katarzyna Unrug-Bielawska, David Earnshaw, Magdalena Cybulska-Lubak, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
Methods in Molecular Biology (Clifton, N.J.)
|
September 30, 2025
A 3D Co-Culture Model of Endometrial Carcinoma Cells with Peripheral Blood Immune Cells (PBMCs) to Study the Activity of Immune Checkpoint Inhibitors
Justyna Kocik-Krol, Marcin Krzykawski
Methods in Molecular Biology (Clifton, N.J.)
|
September 30, 2025
A PD-1/PD-L1-Sensitive Co-culture-Based Primary T-Cell Activation Assay
Justyna Kocik-Krol, Malgorzata Stec, Maciej Siedlar, et al.
International Journal of Molecular Sciences
|
November 13, 2021
PD-L1 Inhibitors: Different Classes, Activities, and Mechanisms of Action
Ewa Surmiak, Katarzyna Magiera-Mularz, Bogdan Musielak, et al.
ACS Medicinal Chemistry Letters
|
July 16, 2025
Characterization of Clinically Evaluated Small-Molecule Inhibitors of PD-L1 for Immunotherapy
Alicja Slota, Katarzyna Golebiowska-Mendroch, Justyna Kocik-Krol, et al.
Molecular Cancer
|
September 7, 2023
Structural and biological characterization of pAC65, a macrocyclic peptide that blocks PD-L1 with equivalent potency to the FDA-approved antibodies
Ismael Rodriguez, Justyna Kocik-Krol, Lukasz Skalniak, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
December 5, 2025
Balancing cell cycle arrest and immune activation: A synergistic window for idasanutlin and anti-PD-1 therapy in a syngeneic mouse model
Aneta Nieznanska, Malgorzata Statkiewicz, Zuzanna Sandowska-Markiewicz, et al.
Molecules (Basel, Switzerland)
|
June 10, 2022
Biphenyl Ether Analogs Containing Pomalidomide as Small-Molecule Inhibitors of the Programmed Cell Death-1/Programmed Cell Death-Ligand 1 Interaction
Shabnam Shaabani, Louis Gadina, Ewa Surmiak, et al.
Journal of Medicinal Chemistry
|
July 27, 2021
Terphenyl-Based Small-Molecule Inhibitors of Programmed Cell Death-1/Programmed Death-Ligand 1 Protein-Protein Interaction
Damian Muszak, Ewa Surmiak, Jacek Plewka, et al.
ACS Medicinal Chemistry Letters
|
January 17, 2024
Solubilizer Tag Effect on PD-L1/Inhibitor Binding Properties for <i>m</i>-Terphenyl Derivatives
Ewa Surmiak, Julia Ząber, Jacek Plewka, et al.
Anticancer Research
|
September 30, 2024
Therapeutic Responses to Two New SN-38 Derivatives in Colorectal Cancer Patient-Derived Xenografts and Respective 3D <i>In Vitro</i> Cultures
Katarzyna Unrug-Bielawska, David Earnshaw, Magdalena Cybulska-Lubak, et al.
Page
of 2